Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine Katsushika Medical Center, Tokyo 125-8506, Japan.
World J Gastroenterol. 2013 Jan 7;19(1):78-85. doi: 10.3748/wjg.v19.i1.78.
To identify factors associated with prognosis of hepatocellular carcinoma (HCC) after initial therapy.
A total of 377 HCC patients who were newly treated at Katsushika Medical Center, Japan from January 2000 to December 2009 and followed up for > 2 years, or died during follow-up, were enrolled. The factors related to survival were first analyzed in 377 patients with HCC tumor stage T1-T4 using multivariate Cox proportional hazards regression analysis. A similar analysis was performed in 282 patients with tumor stage T1-T3. Additionally, factors associated with the period between initial and subsequent therapy were examined in 144 patients who did not show local recurrence. Finally, 214 HCC stage T1-T3 patients who died during the observation period were classified into four groups according to their alcohol consumption and postprandial glucose levels, and differences in their causes of death were examined.
On multivariate Cox proportional hazards regression analysis, the following were significantly associated with survival: underlying liver disease stage [non-cirrhosis/Child-Pugh A vs B/C, hazard ratio (HR): 0.603, 95% CI: 0.417-0.874, P = 0.0079], HCC stage (T1/T2 vs T3/T4, HR: 0.447, 95% CI: 0.347-0.576, P < 0.0001), and mean postprandial plasma glucose after initial therapy (< 200 vs ≥ 200 mg/dL, HR: 0.181, 95% CI: 0.067-0.488, P = 0.0008). In T1-T3 patients, uninterrupted alcohol consumption after initial therapy (no vs yes, HR: 0.641, 95% CI: 0.469-0.877, P = 0.0055) was significant in addition to underlying liver disease stage (non-cirrhosis/Child-Pugh A vs B/C, HR: 0649, 95% CI: 0.476-0.885, P = 0.0068), HCC stage (T1 vs T2/T3, HR: 0.788, 95% CI: 0.653-0.945, P = 0.0108), and mean postprandial plasma glucose after initial therapy (< 200 mg/dL vs ≥ 200 mg/dL, HR: 0.502, 95% CI: 0.337-0.747, P = 0.0005). In patients without local recurrence, time from initial to subsequent therapy for newly emerging HCC was significantly longer in the "postprandial glucose within 200 mg/dL group" than the "postprandial glucose > 200 mg/dL group" (log-rank test, P < 0.05), whereas there was no difference in the period between the "non-alcohol group" (patients who did not drink regularly or those who could reduce their daily consumption to < 20 g) and the "continuation group" (drinkers who continued to drink > 20 g daily). Of 214 T1-T3 patients who died during the observation period, death caused by other than HCC progression was significantly more frequent in "group AL" (patients in the continuation and postprandial glucose within 200 mg/dL groups) than "group N" (patients in the non-alcohol and postprandial glucose within 200 mg/dL groups) (P = 0.0016).
This study found that abstinence from habitual alcohol consumption and intensive care for diabetes mellitus were related to improved prognosis in HCC patients.
确定与初始治疗后肝细胞癌 (HCC) 预后相关的因素。
共纳入 2000 年 1 月至 2009 年 12 月期间在日本葛饰医疗中心新接受治疗、随访时间> 2 年或随访期间死亡的 377 例 HCC 患者。采用多变量 Cox 比例风险回归分析,首先分析 HCC 肿瘤分期为 T1-T4 的 377 例患者的生存相关因素。在肿瘤分期为 T1-T3 的 282 例患者中进行了类似的分析。此外,还在 144 例未出现局部复发的患者中检查了与初始治疗和后续治疗之间时间相关的因素。最后,根据饮酒和餐后血糖水平将 214 例 HCC 分期为 T1-T3 的患者分为四组,并检查了他们的死亡原因。
多变量 Cox 比例风险回归分析显示,以下因素与生存显著相关:基础肝病分期[非肝硬化/Child-Pugh A 与 B/C,风险比 (HR):0.603,95%CI:0.417-0.874,P = 0.0079]、HCC 分期 (T1/T2 与 T3/T4,HR:0.447,95%CI:0.347-0.576,P < 0.0001) 和初始治疗后平均餐后血浆葡萄糖水平(< 200 与≥ 200 mg/dL,HR:0.181,95%CI:0.067-0.488,P = 0.0008)。在 T1-T3 患者中,初始治疗后持续饮酒 (无 vs 是,HR:0.641,95%CI:0.469-0.877,P = 0.0055) 以及基础肝病分期(非肝硬化/Child-Pugh A 与 B/C,HR:0.649,95%CI:0.476-0.885,P = 0.0068)、HCC 分期 (T1 与 T2/T3,HR:0.788,95%CI:0.653-0.945,P = 0.0108) 和初始治疗后平均餐后血浆葡萄糖水平(< 200 mg/dL 与≥ 200 mg/dL,HR:0.502,95%CI:0.337-0.747,P = 0.0005) 同样显著。在无局部复发的患者中,新发 HCC 的初始治疗与后续治疗之间的时间在“餐后血糖< 200 mg/dL 组”明显长于“餐后血糖> 200 mg/dL 组”(对数秩检验,P < 0.05),而“非饮酒组”(不规律饮酒或可将日饮酒量减少至< 20 g 的患者)与“继续饮酒组”(每日继续饮酒> 20 g 的患者)之间无差异。在 214 例在观察期间死亡的 T1-T3 患者中,由于 HCC 进展以外的原因导致的死亡在“group AL”(继续饮酒和餐后血糖< 200 mg/dL 组)中明显多于“group N”(非饮酒和餐后血糖< 200 mg/dL 组) (P = 0.0016)。
本研究发现,习惯性饮酒的戒除和糖尿病的强化护理与 HCC 患者的预后改善相关。